Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

angelman syndrome

POPULAR ARTICLES

Ultragenyx Partners with GeneTx to Advance Treatment for Angelman Syndrome

Ovid Therapeutics Receives Orphan Drug Designation from the European Commission for OV101

Ovid Therapeutics Plans to Move into the Phase 3 Trial Based on End-of-Phase 2 Meeting for OV101

LATEST ARTICLES

Biotech Investing

Ovid Presents Additional Data at AACAP

Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101

Latest News

CEOL Application Process Update

Riverside Resources Receives Final Court Approval for Spin-Out of Blue Jay

Silver47 Announces Its Final Closing of $9.8 Million Non-Brokered Private Placement

Galan Declines AU$240M Bid for Argentina Projects

Close of Takeover Offer